Literature DB >> 20630402

Pathophysiology of anemia in heart failure.

Inder S Anand1.   

Abstract

Renal dysfunction and neurohormonal and proinflammatory cytokine activation appear to contribute to anemia of chronic disease in most patients, resulting in inappropriate erythropoietin production and defective iron utilization. Under normal conditions, reduced tissue oxygenation caused by chronic anemia results in non-hemodynamic and hemodynamic compensatory responses to enhance oxygen carrying capacity. Erythropoiesis is the predominant non-hemodynamic response to hypoxia, but because erythropoiesis is defective in heart failure, hemodynamic mechanisms may predominate in chronic severe anemia. Hemodynamic responses are complex and involve a vasodilation-mediated high-output state with neurohormonal activation. The high output state initially helps to increase oxygen transport. However, the hemodynamic and neurohormonal alterations could potentially have deleterious long-term consequences and may contribute to anemia's role as an independent risk factor for adverse outcomes. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20630402     DOI: 10.1016/j.hfc.2010.03.002

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN: 1551-7136            Impact factor:   3.179


  14 in total

1.  Effects of hypoxia on muscle protein synthesis and anabolic signaling at rest and in response to acute resistance exercise.

Authors:  Timothy Etheridge; Philip J Atherton; Daniel Wilkinson; Anna Selby; Debbie Rankin; Nick Webborn; Kenneth Smith; Peter W Watt
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-12       Impact factor: 4.310

2.  Cardiac function in Ghanaian children with severe malaria.

Authors:  Samuel B Nguah; Torsten Feldt; Steffi Hoffmann; Daniel Pelletier; Daniel Ansong; Justice Sylverken; Parisa Mehrfar; Johanna Herr; Christian Thiel; Stephan Ehrhardt; Gerd D Burchard; Jakob P Cramer
Journal:  Intensive Care Med       Date:  2012-08-14       Impact factor: 17.440

3.  Usefulness of Relative Hypochromia in Risk Stratification for Nonanemic Patients With Chronic Heart Failure.

Authors:  Muhammad Hammadah; Marie-Luise Brennan; Yuping Wu; Stanley L Hazen; W H Wilson Tang
Journal:  Am J Cardiol       Date:  2016-01-28       Impact factor: 2.778

Review 4.  The cardiorenal syndrome in heart failure: cardiac? renal? syndrome?

Authors:  Filippos Triposkiadis; Randall C Starling; Harisios Boudoulas; Gregory Giamouzis; Javed Butler
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 5.  Prevalence and importance of comorbidities in patients with heart failure.

Authors:  Filippos K Triposkiadis; John Skoularigis
Journal:  Curr Heart Fail Rep       Date:  2012-12

6.  Anemia and its association with clinical outcome in heart failure patients undergoing cardiac resynchronization therapy.

Authors:  Ramkumar V Venkateswaran; Carolyn Freeman; Neal Chatterjee; Jagdesh Kandala; Mary Orencole; Eszter M Vegh; Kimberly A Parks; Peter J Cowburn; G William Dec; Jagmeet P Singh; Rasmus Borgquist
Journal:  J Interv Card Electrophysiol       Date:  2015-10-09       Impact factor: 1.900

Review 7.  Anemia and iron deficiency in heart failure.

Authors:  Shanti Gunawardena; Mark E Dunlap
Journal:  Curr Heart Fail Rep       Date:  2012-12

8.  Anemia in heart failure patients.

Authors:  Michael G Alexandrakis; George Tsirakis
Journal:  ISRN Hematol       Date:  2012-03-25

9.  Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF).

Authors:  John J V McMurray; Inder S Anand; Rafael Diaz; Aldo P Maggioni; Christopher O'Connor; Marc A Pfeffer; Scott D Solomon; Michal Tendera; Dirk J van Veldhuisen; Moetaz Albizem; Sunfa Cheng; Debra Scarlata; Karl Swedberg; James B Young
Journal:  Eur J Heart Fail       Date:  2013-01-17       Impact factor: 15.534

10.  Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial.

Authors:  Gerasimos Filippatos; Dimitrios Farmakis; Josep Comin Colet; Kenneth Dickstein; Thomas F Lüscher; Ronnie Willenheimer; John Parissis; Giedrius Gaudesius; Claudio Mori; Barbara von Eisenhart Rothe; Nicola Greenlaw; Ian Ford; Piotr Ponikowski; Stefan D Anker
Journal:  Eur J Heart Fail       Date:  2013-06-19       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.